Canopy Growth Corp (CGC) stock
CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
$0.50−0.03 (-5.63%)
Close on Nov 18, 2026Market cap $212.15MP/E –Yield –
Canopy Growth operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Canopy Growth's operating income for the twelve months ending Jun 30, 2026 was -C$161.15M. For fiscal 2026 it was -C$161.66M. The highest annual figure on record is -C$14.08M in fiscal 2017.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -C$161.66M | – |
| FY2025 | Mar 31, 2025 | -C$117.14M | – |
| FY2024 | Mar 31, 2024 | -C$228.71M | – |
| FY2023 | Mar 31, 2023 | -C$2.63B | – |
| FY2022 | Mar 31, 2022 | -C$1.02B | – |
| FY2021 | Mar 31, 2021 | -C$1.24B | – |
| FY2020 | Mar 31, 2020 | -C$1.67B | – |
| FY2019 | Mar 31, 2019 | -C$637.45M | – |
| FY2018 | Mar 31, 2018 | -C$119.60M | – |
| FY2017 | Mar 31, 2017 | -C$14.08M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -C$22.11M | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -C$95.79M | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -C$26.35M | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -C$16.89M | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -C$22.62M | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -C$18.27M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -C$23.82M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -C$45.94M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -C$29.11M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -C$106.74M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -C$60.32M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -C$7.01M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -C$54.65M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -C$544.78M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -C$112.69M | – |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | -C$149.17M | – |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | -C$1.84B | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -C$465.77M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -C$149.96M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -C$215.36M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -C$187.71M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -C$233.20M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -C$553.61M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -C$284.27M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -C$172.38M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -C$991.02M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -C$192.38M | – |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -C$270.84M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -C$214.72M | – |
See a number that looks wrong?